Creative Planning
XENT

Creative Planning’s Intersect ENT, Inc XENT Stock Holding History

Creative Planning’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,142
Closed -$18K – 4925
2016
Q3 		$18K Buy
+1,142
New +$17.2K ﹤0.01% 3139

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Creative Planning's XENT Position: Q4 2016 in Review

Creative Planning sold out of Intersect ENT, Inc (XENT) in Q4 2016, closing a stake of 1,142 shares — an estimated $18K sold.

Creative Planning first reported a position in XENT in Q3 2016 and held it in 1 quarter. The position peaked at $18K in Q3 2016. 104 funds tracked by Wall St. Rank hold XENT as of Q4 2016.

  • Creative Planning reported no remaining Intersect ENT, Inc position as of Q4 2016 after selling out during the quarter.
  • Creative Planning sold 1,142 Intersect ENT, Inc shares in Q4 2016, an estimated $18K.
  • Creative Planning first reported a position in Intersect ENT, Inc in Q3 2016 and held it in 1 quarter.
  • Creative Planning's Intersect ENT, Inc position peaked at $18K in Q3 2016.
  • 104 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2016.

Based on Creative Planning's 13F filing for Q4 2016, filed 9 Jan 2017.